ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ASRT Assertio Holdings Inc

1.00
0.00 (0.00%)
Pre Market
Last Updated: 06:00:06
Delayed by 15 minutes

Period:

Draw Mode:

Volume 59
Bid Price 1.00
Ask Price 1.03
News -
Day High

Low
0.7324

52 Week Range

High
6.57

Day Low
Share Name Share Symbol Market Stock Type
Assertio Holdings Inc ASRT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.00 06:00:06
Open Price Low Price High Price Close Price Previous Close
1.00
Trades Shares Traded Average Volume 52 Week Range
2 59 - 0.7324 - 6.57
Last Trade Type Quantity Price Currency
03:05:09 9 US$ 1.03 USD

Assertio Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
95M 95.00M - 152.07M -331.94M -3.49 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Assertio News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ASRT Message Board. Create One! See More Posts on ASRT Message Board See More Message Board Posts

Historical ASRT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.031.050.9911.02433,372-0.03-2.91%
1 Month0.841.2550.831.05805,9560.1619.05%
3 Months0.881.2550.73240.98364321,030,8570.1213.64%
6 Months1.171.2550.73240.97984781,026,706-0.17-14.53%
1 Year6.506.570.73242.671,496,462-5.50-84.62%
3 Years1.868.010.73243.211,277,600-0.86-46.24%
5 Years3.4010.050.331.662,320,311-2.40-70.59%

Assertio Description

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Your Recent History

Delayed Upgrade Clock